© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
958805 |
As an accredited 6-Bromo-1,4-Dihydro-2H-3,1-Benzoxazine-2-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-1,4-Dihydro-2H-3,1-Benzoxazine-2-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As someone who has come to rely on organic intermediates for both practical research and real-world innovation, I know firsthand how a single molecular tweak can reshape an industry standard. 6-Bromo-1,4-Dihydro-2H-3,1-Benzoxazine-2-One stands out among aromatic compounds not simply because of its chemical lineage but due to the flexibility and structure it brings to synthesis. Compared with general-purpose benzoxazines, the 6-bromo substitution offers options for directed reactivity that make a real difference in the lab and in manufacturing.
Not every intermediate gets its own dedicated production line, but the precise identity of 6-Bromo-1,4-Dihydro-2H-3,1-Benzoxazine-2-One has made it a mainstay where selectivity and traceability count. With a molecular formula of C8H6BrNO2, and a characteristic fused aromatic ring system, it offers a blend of stability and reactivity. The strong presence of bromine on the sixth carbon brings both weight and chemical utility. Its molecular weight positions it well for downstream transformations, and the crystalline appearance aids in handling and storage, particularly compared to oilier analogs. For chemists, visual cues and physical properties go hand-in-hand with purity checks and documentation.
Chemists appreciate predictability, and this compound doesn’t disappoint. Its melting range sits comfortably in the moderate zone, typically making purification less of a headache for those who have struggled with stubborn oily contaminants. Solubility here is defined by its semi-polar backbone; organic ester solvents handle it with ease, while water solubility remains low. This specificity narrows down which processes make the most sense, but in turn, reduces cross-reactivity with undesired substances. It has found regular use in controlled multistep reactions, where side products can mean wasted effort and lost yield.
Some benzoxazines never leave the academic shelves, yet the 6-bromo derivative has made its way into genuine industrial demand. Its strongest presence shows in pharmaceutical intermediate synthesis. The incorporation of bromine provides a reactive handle for further halogenation, Suzuki-Miyaura couplings, and nucleophilic substitutions —each of which has broad value for building complex molecules. In agrochemical research, this scaffold supports the construction of agents with targeted biological profiles, supporting innovation in field chemistry and crop protection. Fine chemical houses frequently seek it for its reproducible behavior and the low occurrence of troublesome impurities, allowing for products with tighter batch-to-batch reproducibility, which can affect product registration and compliance in global supply chains.
While people often talk about chemical intermediates as if they’re interchangeable, any synthetic chemist knows that small molecular changes drive big differences. The bromo group at position six doesn’t simply add mass; it opens up entire new reaction pathways. Halogen-containing intermediates offer more than just reactivity—they bring selectivity. The meta interaction here gives chemists additional levers for regioselective transformations, supporting the development of active pharmaceutical ingredients that call for this level of nuance. In my own research, the move from a simple benzoxazine to this 6-bromo variant shaved hours off reaction optimization and ultimately lifted overall yield. These gains, modest as they may seem, compound across dozens of steps and thousands of grams. In competitive sectors, this is a game changer.
Process reliability matters as much as reactivity in regulated industries. Reliable 6-bromo-1,4-dihydro-2H-3,1-benzoxazine-2-one ships with certificates of analysis, documenting not just purity over 98%, but residual solvents, water content, and heavy metal traces. Regulatory agencies keep tightening guidelines, so tighter controls at this stage save headaches downstream. I have seen product recalls hinge on intermediate purity, especially when later-stage manufacturing depends on well-defined starting materials. As a result, consistency here supports timely product registration and regulatory submissions, both for pharma and specialty chemicals.
Ordinary organic syntheses rarely count sustainability as a built-in feature. In the past, brominated aromatics got fingers pointed at them for toxicity or legacy waste. Supply chains today handle these materials with more awareness. Many suppliers of this benzoxazine now report detailed origin and handling protocols, and some transparency has been brought into waste minimization strategies. Electrochemical bromination routes have begun to replace traditional methods, curbing waste and energy use. For green chemistry practitioners, 6-bromo-1,4-dihydro-2H-3,1-benzoxazine-2-one offers a compromise: reliable functionality, plus a path to trackable and auditable use.
Anyone who has worked with halogenated aromatics knows they require respect in handling. This compound, with its solid crystalline form and limited volatility, poses less immediate risk compared to its chlorinated or fluorinated relatives. Traditional risks revolve around consistent PPE and careful weighing rather than acute exposure incidents. Modern synthesis protocols often keep operators from direct inhalation or skin contact, and good practice in ventilation and spill response can further reduce risk.
One practical issue arises in waste management—brominated by-products can linger in the environment. Labs and plants with proper scrubbing or incineration systems mitigate much of this risk, but ongoing diligence from management teams ensures that regulatory fines or compliance shortfalls don’t creep in through the back door.
Formulators now expect intermediates to fit cleanly into automated processes. 6-bromo-1,4-dihydro-2H-3,1-benzoxazine-2-one’s relatively high melting point and pure crystalline form lend themselves well to feeding systems, reducing clogs or feed interruptions in industrial-scale reactors. For research-sized batches, its manageable dusting and low static behavior make manual handling believable, rather than a frustrating battle with powdery mess.
Its defined functional groups provide reactivity just where it’s wanted. In practice, this means that protection/deprotection steps can sometimes be skipped, allowing teams to move from conception to bench-scale trial faster. The more I use this intermediate, the more I come to appreciate incremental time savings in otherwise tedious synthesis protocols.
Some look at benzoxazines as a broad class, but stacking them side by side quickly reveals major differences. Basic, unsubstituted benzoxazines lack the same scope for onward functionalization. Moving to the bromo-bearing version at position six alters electronic density, affecting how ease of nitration, halogen exchange, and coupling chemistry plays out. Many competitive products come with either mixed substitution patterns or extra functional groups that add purification headaches. The 6-bromo isomer stands out for the rare balance it strikes: versatile enough for further synthesis steps, but clean enough that downstream applications don’t stumble over undesired impurities. Colleagues involved in scale-up have reported that, compared to iodo- or chloro-analogues, the bromo variant avoids both undesirable cost escalations and more stringent environmental regulations, offering a sustainable middle ground.
Reliable supply of this compound has opened the gates for rapid exploration in drug discovery, agricultural chemistry, and advanced materials. Academic partnerships often look to derivatives with pre-installed halogen substituents like this because they translate straight into new ligand design or bioisosteric swaps. In the past year alone, multiple groups have posted promising leads for kinase inhibitors and neuroactive agents using this starting point. For those charting new territory, easy access allows resources to shift from precursor synthesis toward structure-activity screening.
Materials science teams have begun to eye benzoxazine derivatives for advanced polymer formation, with the bromo group offering a lever for tailored cross-linking steps. In real-world settings—coating technologies, advanced composites—getting the right bridge between processability and physicochemical resilience depends on smart intermediate selection at the front end.
A few years ago, this compound could be surprisingly hard to secure in reliable quantities. Expansion in contract manufacturing and better synthesis routes have changed that. Most large-scale dealers now carry stocks that reflect regular demand, and regional warehouses cut down on long shipping waits. For those operating in regulated markets, traceable chain of custody supports compliance with both import/export controls and in-house audits. The feedback from purchasing teams shows that predictable availability strengthens planning down the line, from pilot batches to full-scale commercial rollout.
Cost remains a live issue with any specialty intermediate. Early runs were dogged by expensive bromine sources and low-yield syntheses. Improvements in route design and economies of scale have brought costs in line with other high-purity halogen intermediates. Operational savings from tighter downstream yields and fewer purification steps also factor in. My own experience sorting through financials on mid-scale synthesis runs has taught me to weigh upfront purchase price against minimized wastage. This bromo benzoxazine usually returns value with fewer column runs and less rework, supporting an overall leaner process.
Over the past decade, the relationship between basic chemical intermediates and innovation has tightened. Teams from universities, startups, and multinational firms want building blocks that cut both cost and cycle time. The unique substitution pattern here has found favor beyond those strictly following academic protocols. Experts in medicinal chemistry praise it for strategic scaffold hopping; process engineers focus on its cooperative behavior in automation. Even in less headline-grabbing areas, such as pigment design or lubricant additive formulation, the management of reactivity and purification cascades from this single molecular design choice.
One lesson from working at the interface between research and manufacturing: better intermediates mean better products at the end of the line. Those who invest up front in materials selection often see smoother regulatory reviews and stronger IP around process design. With new regulatory regimes on the horizon for brominated compounds, early adopters of traceable, well-specified intermediates stand to benefit.
No foundation chemical stands still forever. The challenge for 6-bromo-1,4-dihydro-2H-3,1-benzoxazine-2-one now involves adapting not just to scaling pressures, but to new process intensification approaches, flow chemistry systems, and ever-shrinking tolerances on impurity profiles. Sustainability expectations are rising in lockstep with scrutiny from both customers and public regulators. Success over the coming years will rest on embracing quality assurance and adoption of greener synthesis technologies.
Chemical manufacturers looking to maintain leadership will lean into transparency: publishing environmental impact data, third-party audits, and life cycle analyses. Not every buyer will demand these, but those at the cutting edge of pharmaceuticals and specialty materials certainly will.
Looking back across projects where this intermediate played a part, its real strength begins with reliable, targeted reactivity and extends straight to the bottom line through cost control and process efficiency. Access to a well-characterized, high-purity version clears a path from lab bench to commercial plant with fewer bottlenecks. Trends suggest growing demand in both established markets and new application spaces, driven by the compound’s rare combination of reactivity and manageable environmental profile.
Collaboration between suppliers, users, and regulatory bodies promises to safeguard both quality and supply stability over the long haul. For the next generation of chemical innovation—whether that means safer pharmaceuticals, greener agrochemicals, or resilient new materials—6-bromo-1,4-dihydro-2H-3,1-benzoxazine-2-one stands ready as a trusted partner in the pursuit of progress.
